Profound Medical Corp. (PRN:CA) Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer Transcript

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...
Le Lézard

Registrational Phase III AMPLIFY trial: Target number of participants achieved

Clarity Pharmaceuticals ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with ...
IEEE

Untrained Neural Network-Based Full-Waveform Inversion for Breast Sound Speed Imaging in Ultrasound Computed Tomography

Abstract: Quantitative imaging represents a pivotal advantage of ultrasound computed tomography (USCT), significantly distinguishing it from conventional ultrasound imaging techniques. Especially, ...
Nation

Growing up with cancer: One family’s long battle across generations

The disease entered Linda Adhiambo’s family in 2007 and never left. It has taken her mother, grandmother, aunt and cousins. Now, as she battles breast cancer, she asks: when will this cycle end?